Cargando...
Diphtheria toxin‐based anti‐human CD19 immunotoxin for targeting human CD19(+) tumors
CD19 is expressed on normal and neoplastic B cells and is a promising target for immunotherapy. However, there is still an unmet need to further develop novel therapeutic drugs for the treatment of the refractory/relapsing human CD19(+) tumors. We have developed a diphtheria toxin‐based anti‐human C...
Guardado en:
| Publicado en: | Mol Oncol |
|---|---|
| Autores principales: | , , , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
John Wiley and Sons Inc.
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5527461/ https://ncbi.nlm.nih.gov/pubmed/28306193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12056 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|